Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Vaccines without chemicals, FDA fast track for Vanelva's chikungunya vaccine, and Marburg virus found in bats in West Africa

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

USAID celebrates 50 years of saving lives across the globe

Today, the US Agency for International Development (USAID) celebrates 50 years of leadership and expertise in addressing development challenges to improve lives across the globe.

GHTC
Read More
Step One

Don Joseph is Chief Operating Officer at BIO Ventures for Global Health (BVGH), a GHTC member, and wrote this blog post in conjunction with the launch of WIPO Re:Search, a new consortium where public and private sector organizations share valuable intellectual property (IP) and expertise with the global health research community to promote development of new drugs, vaccines, and diagnostics to treat neglected tropical diseases, malaria, and tuberculosis.

Read More
What's Ahead on the Hill

In this regular feature on Breakthroughs, Ashley Bennett, senior policy associate at the GHTC, provides an update on what’s currently happening with global health in Congress and an outlook for future legislative activity.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What We're Reading This Week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Patrick McKern
TAG releases report on global TB R&D investment trends

TAG has released a new report in collaboration with the Stop TB Partnership, which finds that in 2010 the world invested just $617 million in TB R&D—less than one-third of the estimated $2 billion annual investment needed to eliminate TB as a public health threat by the year 2050.

Treatment Action Group
Read More
Kenya: On the verge of breakthroughs in global health

Some of the most incredible health research is taking place in Kenya right now. Because of this work, we are on the cusp of the most exciting new tools in global public health in recent years—the first ever malaria vaccine, gels women can use to protect themselves from HIV, new drugs for neglected diseases that affect the poorest of the poor.

GHTC
Read More
PATH/Will Boase
World Health Summit highlights creative funding for new global health products

The third annual World Health Summit is currently underway in Berlin. The Summit brings together researchers, policymakers, funders, advocates, and health care providers to discuss global public health policy and research.

PATH
Read More
Investing in high-impact, low-cost innovations that save lives

A new mother experiencing excessive bleeding after childbirth can die within minutes if the bleeding isn’t stopped. For women in developing countries, time too often runs out before they can get help.

PATH
Read More
What's Ahead on the Hill

Congress continues to debate how to keep the government running in the midst of a rollercoaster appropriations process, while at home and abroad global health research and development (R&D) programs struggle to continue their work and simultaneously juggle looming funding reductions.

GHTC
Read More
Evelyn Hockstein/PATH
GHTC in Kenya: A Photo Journey

This week, the GHTC is in Kenya, meeting with several GHTC members conducting ground-breaking work.

GHTC
Read More
PATH/Gabe Bienczycki
Research needed to overcome stunning shortcomings in TB tools

John Donnelly, a writer working with the GHTC, is blogging following our trip to visit global health research projects in Kenya. This is his third post from the field.

Read More
‘These drugs work. I will live to see my grandchildren’

John Donnelly, a writer working with the GHTC, will be blogging this week from our trip to visit global health research projects in Kenya. This is his second post from the field.

Read More
PATH/Glenn Austin
Children in need of better diagnostics

GHTC’s Kim Lufkin is in Kenya this week, documenting global health research projects and the impact on people in the country. This is her first post from the field.

GHTC
Read More
Q&A: US Global Health Work in Kenya with Kemy Monahan

Katherine E. “Kemy” Monahan, a career foreign service officer steeped in development issues and an economist and lawyer by training, was appointed as deputy executive director of the Global Health Initiative (GHI) in July. She talked to GHTC’s Breakthroughs blog about her impressions of the US global health work in Kenya, the importance of research, and the critical need now to make the case to Congress for investing in global health.

GHTC
Read More
PATH/Evelyn Hockstein
CDC in Kibera: Closely monitoring diseases, outbreaks in a slum

Inside a large room at the US Embassy in Nairobi, Robert F. Breiman, MD, the country director for the Centers for Disease Control and Prevention (CDC) in Kenya, explained a portion of the US-funded research in Nairobi’s largest slum, Kibera.

Read More
alex-dehgan
Global Health R&D with USAID's Alex Dehgan

During USAID’s 50th year, there’s a lot of talk about helping women in the developing world.

GHTC
Read More
follow-us-in-kenya
Follow us in Kenya!

This is an exciting week for the GHTC. Not only are we launching our “Breakthroughs” blog, but we’re also taking off on an amazing trip to Kenya to discover how global health research is changing people’s lives on the ground.

GHTC
Read More
Welcome to the Global Health Technologies Coalition’s new blog: Breakthroughs

Here at the GHTC, our team is dedicated to the idea that it’s possible to find new health solutions that will save countless lives around the world. From the first-ever vaccine to prevent malaria, to a ground-breaking gel that can prevent HIV infection, to new, simpler regimens to treat TB, we believe that science can and will deliver the tools we need to eliminate some of the world’s deadliest diseases.

GHTC
Read More